🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
The main objective of this study is to observe and evaluate the safety and ...
Status
Recruiting
Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2025-05-30
Trial ID
NCT06980155
Treatments Being Tested
To learn if the drug combination of tiragolumab and ivonescimab can help to...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-07-28
Trial ID
NCT07038915
Treatments Being Tested
This study is a multicenter, prospective, randomized phase II trial aimed a...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2024-03-01
Trial ID
NCT06272214
Treatments Being Tested
In registry studies of CAR-T products that have been marketed globally, pat...
Status
Unknown
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2023-06-10
Trial ID
NCT05871684
Treatments Being Tested
This study is a card Rayleigh bead single combined cisplatin treatment of a...
Status
Unknown
Location
Department of Bone and Soft Tissue ,Henan Cancer Hospital
Start Date
2022-08-05
Trial ID
NCT05490485
Treatments Being Tested
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
This is a phase II Randomized comparison clinical trial of activated CIK ar...
Status
Withdrawn
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Start Date
2018-04-10
Trial ID
NCT03540199
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
This is an investigator-initiated, multi-center, open-label clinical study ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07-31
Trial ID
NCT06528249